Picture of Clontarf Energy logo

CLON Clontarf Energy News Story

0.000.00%
gb flag iconLast trade - 00:00
EnergyHighly SpeculativeMicro CapSucker Stock

REG - Clontarf Energy PLC - Interim Results for the period ended 30 June 2025

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250910:nRSJ6701Ya&default-theme=true

RNS Number : 6701Y  Clontarf Energy PLC  10 September 2025

10(th) September 2025

 

Clontarf Energy plc

("Clontarf" or the "Company")

 

Interim Statement for the period ended 30 June 2025

 

Clontarf Energy plc (AIM: CLON), the energy company focused on clean Bolivian
Lithium brines, as well as petroleum in Australia and Africa, announces its
unaudited financial results for the six months ended 30 June 2025:

 

 

Industry and Company Highlights

 

Innovating Direct Lithium & Magnesium Extraction from brines:

 

·    Our confidence in the potential of new Direct Extraction Techniques
to transform the industry by increasing purities, minimising deleterious
elements, and boosting throughput, has been vindicated through test-work
recently undertaken:

 

·    Laboratory & pilot plant testing of samples provided by YLB, and
previous sampling campaigns, as well as synthetic brines, are highly
encouraging - as are more extensive brines' production runs, including those
based on observed Uyuni chemistries.

 

·    By solving, together with our technical partners, the need to extract
100% of contained Magnesium, we have opened up potentially two independent
income streams - both Lithium and Magnesium.

 

·   The initial pilot plant of our JV technical partner NEXT-ChemX is
progressing well at a trusted partner's industrial site in India.  We now
have the technical and commercial confidence to build larger-scale production
plants, whether in Bolivia or elsewhere, as soon as legal and commercial
requirements are satisfied.

 

·   The Magnesium breakthrough may enable development of salares, in
additional countries, that would not have been economic at current prices
through production of their Lithium content alone.

 

·    Concern over security of supply of both mining and processing of
Critical Resource Minerals is now mainstream - not just in Japan and China,
but also in the USA and Europe.  Off-takers are now more open to financing
arrangements for juniors, while EU funding is available for infrastructural
development.

 

·   The next stage is to complete and implement the revised Memorandum of
Understanding, and process further even larger brine volumes containing
Magnesium as well as traditional salts through the pilot-plant in India.

 

·  There is strong market interest in long-term offtake contracts for
reliable, high-purity clean Lithium and Magnesium from brines - at higher than
current spot prices.

 

Chairman's Statement

 

Recent months have witnessed accelerated work on Clontarf's key projects on
several fronts.

 

Attitudes and management of Critical Resource Minerals are being transformed
worldwide, as players grasp the scale and importance of securing adequate
supplies of clean materials.  We believe there are inadequate fresh projects
to deliver the anticipated demand.

 

Offtakers worldwide are now keenly aware of the need to secure reliable, clean
and competitive materials.  It is hard to express how procurement attitudes
have changed since 2000 - prompted by a successful Chinese industrial policy,
which Europe and the USA have now been forced to counter.

 

Historically, Washington and Brussels have been thought of as slow-moving
behemoths, but the fast adoption and funding of the USA's Inflation Reduction
Act, and the EU Commission's Critical Resource Minerals Act, shows how fast
policy-makers can move when realisation of vulnerability dawns.  The EU
Commission has pulled together a "Team Europe" of explorers, miners,
processors and financiers to deliver some measure of materials diversity.

 

The EU Commission's 'dream-team' focuses on practical steps necessary to
reduce dependence on mining and processing in potentially hostile regions.
Included are financiers, refiners, chemical production experts, state and EU
players, as well as explorers and developers.  It is the Board's belief that
operators like Clontarf are key to achieving these objectives.

 

Bolivia has committed itself to becoming a key supplier to all key markets.
This requires urgent de-bottlenecking of licensing, clearer legal title,
financing arrangements and high-throughput production of battery-grade Lithium
salts.  For example, Clontarf saw how EU Global Gateway funds can provide
20-year money at circa 3% interest for state-allocated infrastructure projects
to support new operations in fresh regions.  This effectively funds
two-thirds of total capex, while meeting EU controls and respecting Bolivian
sovereignty.

 

Our process does not use significant volumes of fresh water, involve high
electricity use or toxic chemicals, but there are sensitivities surrounding
some alternative technologies used by other companies.  Accordingly, all
participating companies have been discreet on progress in country.

 

Since late-2024, the authorities have focused on the maturity of the
technology offered, especially whether an operating pilot plant is already
commissioned - as well as financial criteria.  This makes sense, since a
proven Direct Lithium Extraction ("DLE") technology can be funded by
offtakers, who are keen to secure supplies of battery-grade Lithium.  With
proven technologies, many companies will be in a position to negotiate
development contracts.

 

Following technical breakthroughs at our pilot facilities, we have worked on
the chemical and operating engineering necessary to scale-up the process,
while maintaining high quality and competitive costs.  Once the authorities
are comfortable with, and sign-off on this more detailed engineering phase, we
anticipate early despatch of large bulk samples, to be followed by site-visits
to pilot-plants, as originally planned.

 

The recent Bolivian elections signalled a shift to more pro-business policies
in order to accelerate growth, including the growth of commodity exports as
well as to resolve consumer shortages due to a controlled currency and
subsidies.

 

If confirmed in the second round scheduled for October 2025, it is likely that
the new administration will accelerate reform of the Lithium Law.  Similar
arguments suggest reform of the Hydrocarbon Law, which would end the 20-year
exploration strike and re-open efforts to tap Bolivia's substantial gas and
condensate potential.  Last time exploration was pursued vigorously, from
1995 through 2000, Bolivian achieved the world's 2(nd) largest addition of oil
& gas barrels equivalent (after Angola).

 

Positive test results have encouraged us to further expand bulk testing,
especially for the improved Magnesium extraction techniques.

 

Clontarf has sourced the required Intermediate Bulk Containers ("IBCs"), to
ship the bulk samples to Mumbai, in whatever volumes are agreed.

 

The Company originally planned to deploy a pilot-plant to one or more Bolivian
salares during summer 2024.  Because of logistics and weather issues, the
Bolivian authorities opted for the operating companies to remain in their
original plant location, until YLB could conduct due diligence visits.

 

On arrival at our partners' Indian plant which is expected to occur about 2
months after export, the Bolivian bulk samples will be expedited through the
production process.  Larger bulk samples will help us plan to optimise
recovery and throughput not just for Lithium, but also for Magnesium and other
economic minerals.

 

Assuming positive results, we are proposing to open agreement negotiations as
soon as appropriate. Clontarf Energy is hoping to deploy a pilot plant (at a
scale of 500 tonnes / year) to a Bolivian site for arrival ideally by mid-2026
(i.e. six to seven months after arrival of the bulk samples at the Indian
plant), after which it will be promptly commissioned, connected to power and
brine sources, under applicable laws, and start work.  All such schedules
are subject to permitting and applicable rules.

 

Longer-term, the Company plans to deploy an additional production plant to a
total of five separate salares, adding a new plant every six months.  Our
plant size will accord with any restrictions under law, initially at a scale
of 500 tonnes / year.

 

Clontarf Energy's long-term aim is to produce 150,000 tonnes of LCE by 2030.

 

 

Funding

 

Clontarf has successfully tapped the financial markets when necessary. Subject
to technical verification and permitting of its exploration projects, Clontarf
is confident of adequate funding, whether in London or Australia, for near to
medium-term ongoing activities.  Our preference, where possible, is to avoid
dilution by relying on offtakers or EU institutions for necessary
infrastructural support.

It is our belief that the projected offtaker demand for clean high-purity
Lithium cannot be met without Bolivian supplies.

 

 

 

David Horgan

Chairman

9(th) September 2025

 

 

 

 

 

 

 CONDENSED CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME

                                                  Six Months Ended                                                                      Year Ended
                                                  30 June 25                                30 June 24                                  31 Dec 24
                                                  unaudited                                 unaudited                                   audited
                                                  £'000                                     £'000                                       £'000

 Administrative expenses                          (158)                                     (334)                                       (592)
 Impairment of exploration and evaluation assets  (87)                                      (69)                                        (173)

 LOSS BEFORE TAXATION                             (245)                                     (403)                                       (765)

 Income Tax                                                           -                                          -                                            -

 COMPREHENSIVE INCOME FOR THE PERIOD              (245)                                     (403)                                       (765)

 LOSS PER SHARE - basic and diluted                (0.003p)                                  (0.01p)                                     (0.01p)

 

 

 CONDENSED CONSOLIDATED BALANCE SHEET
                                       30 June 25                         30 June 24                                  31 Dec 24
                                        unaudited                          unaudited                                   audited
                                        £'000                              £'000                                       £'000
 ASSETS:
 NON-CURRENT ASSETS
 Intangible assets                                   434                                  625                                         521
 Investment in Joint Venture                         888                                  888                                         888
                                                  1,322                                1,513                                       1,409

 CURRENT ASSETS
 Other receivables                                     39                                      -                                        13
 Cash and cash equivalents                           579                                  601                                         818
                                                     618                                  601                                         831

 TOTAL ASSETS                                     1,940                                2,114                                       2,240

 LIABILITIES:
 CURRENT LIABILITIES
 Trade and other liabilities           (1,356)                            (1,439)                                     (1,411)
                                       (1,356)                            (1,439)                                     (1,411)

 TOTAL LIABILITIES                     (1,356)                            (1,439)                                     (1,411)
 NET LIABILITES                                      584                                  675                                         829

 EQUITY
 Called-up share capital                          6,509                                6,409                                       6,509
 Share premium                                  13,517                              13,195                                       13,517
 Share based payment reserve                         825                                  731                                         825
 Retained deficit                      (20,267)                           (19,660)                                    (20,022)
 TOTAL EQUITY                                        584                                  675                                         829

 

 CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN EQUITY
                              Called-up                                                                   Share based
                              Share                                 Share                                 Payment                                   Retained
                              Capital                               Premium                               Reserves                                  Deficit                                     Total
                              £'000                                 £'000                                 £'000                                     £'000                                       £'000

 As at 1 January 2024                 6,209                               12,737                                       615                         (19,257)                                                    304
 Shares issued                           200                                   500                                                                                                                             700
 Share issue expenses                          -                   (42)                                                      -                                          -                      (42)
 Share based payment charge                    -                                     -                                 116                                              -                                      116
 Total comprehensive income                                                                                                                        (403)                                       (403)
 As at 30 June 2024                   6,409                               13,195                                       731                         (19,660)                                                    675

 Shares issued                           100                                   350                                           -                                          -                                      450
 Share issue expenses                          -                   (28)                                                      -                                          -                      (28)
 Share based payment charge                                                                                              94                                                                                      94
 Total comprehensive income                                                                                                  -                     (362)                                       (362)
 As at 31 December 2024               6,509                               13,517                                       825                         (20,022)                                                    829
 Total comprehensive income                    -                                     -                                       -                     (245)                                       (245)
 As at 30 June 2025                   6,509                               13,517                                       825                         (20,267)                                                    584

 

 

 CONDENSED CONSOLIDATED CASH FLOW                       Six Months Ended                                                                      Year Ended
                                                        30 June 25                                30 June 24                                  31 Dec 24
                                                        unaudited                                 unaudited                                   audited
                                                        £'000                                     £'000                                       £'000
 CASH FLOW USED IN OPERATING ACTIVITIES
 Loss for the period                                   (245)                                     (403)                                       (765)
 Impairment of exploration and evaluation assets                       87                                          69                                        173
 Share based payment charge                                                -                                     116                                         210
 Exchange movements                                                        -                                         1                                            3
                                                       (158)                                     (217)                                       (379)

 Increase in other receivables                         (26)                                                           -                      (13)
 Decrease in trade and other payables                  (55)                                      (21)                                        (49)
 MOVEMENTS IN WORKING CAPITAL                          (81)                                      (21)                                        (62)

 NET CASH USED IN OPERATING ACTIVITIES                 (239)                                     (238)                                       (441)

 CASH FLOWS USED IN INVESTING ACTIVITIES
 Payments for intangible assets                                            -                                          -                                            -
 NET CASH USED IN INVESTING ACTIVITIES                                     -                                          -                                            -

 CASH FLOW FROM FINANCING ACTIVITIES
 Issue of shares                                                         -                       700                                         1,150
 Share issue expenses                                                    -                       (42)                                        (70)
 NET CASH GENERATED FROM FINANCING ACTIVITIES          -                                         658                                         1,080

 NET (DECREASE)/INCREASE IN CASH AND CASH EQUIVALENTS  (239)                                                     420                                         639

 Cash and cash equivalents at beginning of the period                818                                         182                                         182
 Exchange loss on cash and cash equivalents                                -                     (1)                                         (3)
 CASH AND CASH EQUIVALENT AT THE END OF THE PERIOD                   579                                         601                                         818

 

 

Notes:

 

1.    INFORMATION

 

The financial information for the six months ended 30 June 2025 and the
comparative amounts for the six months ended 30 June 2024 are unaudited. The
financial information above does not constitute full statutory accounts within
the meaning of section 434 of the Companies Act 2006.

 

The Interim Financial Report has been prepared in accordance with IAS 34
Interim Financial Reporting as adopted by the U.K. The accounting policies and
methods of computation used in the preparation of the Interim Financial Report
are consistent with those used in the Group 2024 Annual Report, which is
available at www.clontarfenergy.com (http://www.clontarfenergy.com)

 

The interim financial statements have not been audited or reviewed by the
auditors of the Group pursuant to the Auditing Practices board guidance on
Review of Interim Financial Information.

 

 

2.    DIVIDEND

 

No dividend is proposed in respect of the period.

 

 

3.    LOSS PER SHARE

 

Basic loss per share is computed by dividing the loss after taxation for the
year attributable to ordinary shareholders by the weighted average number of
ordinary shares in issue and ranking for dividend during the year. Diluted
earnings per share is computed by dividing the loss after taxation for the
year by the weighted average number of ordinary shares in issue, adjusted for
the effect of all dilutive potential ordinary shares that were outstanding
during the year.

 

 

The following table sets out the computation for basic and diluted earnings
per share ("EPS"):

 

                              Six Months Ended              Year Ended
                              30 June 25     30 June 24     31 Dec 24
 Numerator                    £'000          £'000          £'000
 Loss for the year            (245)          (403)          (765)

 Denominator                  Number         Number         Number
 For basic and diluted EPS    8,193,326,117  6,025,351,235  6,884,911,244

 Basic and diluted EPS        (0.003p)       (0.01p)        (0.01p)

 

 

The following potential ordinary shares are anti-dilutive and are therefore
excluded from the weighted average number of shares for the purposes of the
diluted earnings per share

 

                30 June 25  30 June 24  31 Dec 24
                Number      Number      Number
                '000        '000        '000

 Share options  (980)       (820)       (980)

 

 

 

4.    INTANGIBLE ASSETS

                                    30 June 25  30 June 24  31 Dec 24
                                    £'000       £'000       £'000
 Exploration and evaluation assets
 Cost:
 At 1 January                       12,735      12,735      12,735
 Additions                          -           -           -
 Closing Balance                    12,735      12,735      12,735

 Impairment:
 At 1 January                       12,214      12,041      12,041
 Provision for impairment           87          69          173
 Closing Balance                    12,301      12,110      12,214

 Carrying value:
 At 1 January                       521         694         694
 At period end                      434         625         521

 

 

Exploration and evaluation assets relate to expenditure incurred in
prospecting and exploration for lithium, oil and gas in Bolivia and Ghana. The
directors are aware that by its nature there is an inherent uncertainty in
exploration and evaluation assets and therefore inherent uncertainty in
relation to the carrying value of capitalised exploration and evaluation
assets.

 

During 2018 the Group resolved the outstanding issues with the Ghana National
Petroleum Company (GNPC) regarding a contract for the development of the Tano
2A Block. The Group has signed a Petroleum Agreement in relation to the block
and this agreement awaits ratification by the Ghanian government.

 

As ratification has not yet been achieved,, as a matter of prudence, the
directors opted to write down 20% of the carrying value of the Tano 2A Block
historic expenditure.  Accordingly, an impairment charge of £173,609 was
recorded in the prior and £86,805 in the current period.

 

The directors believe that there were no facts or circumstances indicating
that the carrying value of the remaining intangible assets may exceed their
recoverable amount and thus no impairment review was deemed necessary by the
directors. The realisation of these intangibles assets is dependent on the
successful discovery and development of economic deposit resources and the
ability of the Group to raise sufficient finance to develop the projects. It
is subject to a number of potential significant risks, as set out below.

 

The Group's activities are subject to a number of significant potential risks
including:

 

·        licence obligations;

·        exchange rate risks;

·        uncertainties over development and operational costs;

·        political and legal risks, including agreements with
Governments for licences, profit sharing and taxation;

·        foreign investment risks including increases in taxes,
royalties and renegotiation of contracts;

·        title to assets;

·        financial risk management;

·        going concern; and

·        ability to raise finance.

 

 

 

 

 

5.    INVESTMENT IN JOINT VENTURE

 

                  30 June 25  30 June 24  31 Dec 24
                  £'000       £'000       £'000
 Cost:
 At 1 January     888         888         888
 Additions        -           -           -
 Closing Balance  888         888         888
 Carrying value:
 At period end    888         888         888

 

On 15 February 2023 the Group announced a heads of agreement around the
potential formation of a 50:50 Joint Venture with US based, OTC Markets
traded, technology company, NEXT-ChemX Corporation ("NCX") covering testing,
marketing, and deploying of NCX's proprietary (patent pending) Direct Lithium
Extraction ("DLE") technology in Bolivia. Formation of the JV was subject to
final due diligence and the parties entering into formal documentation.

 

           The terms of the JV are:

§  A 50:50 joint venture company to be formed on completion of due
diligence covering the exclusive rights to the marketing, testing and
deployment of the NCX DLE technology in Bolivia.

§  Clontarf Energy plc to contribute $500,000 in cash towards the pilot
plant construction and testing as an exclusivity fee for the use of the NCX
technology.

§  NCX will then issue shares equal to $500,000 at its next financing
(CHMX:OTC) to Clontarf Energy plc.

§  Clontarf Energy plc will issue shares as follows to NCX:

i.     385 million new Ordinary Shares on proceeding with the Pilot Plant;

ii.    250 million new Ordinary Shares after successful pilot processing of
Bolivian brines through the NCX pilot plant; and

iii. 250 million new Ordinary Shares after entry into a construction and
processing contract between the JV and the Bolivian authorities on processing
of Bolivian brines utilising NCX processing technology.

          On 5 May 2023 the Company announced that all conditions had
been satisfied with respect to the JV with NCX coming into force. In this
regard, Clontarf paid NCX US$500,000 and issued 385 million new Ordinary
Shares in the capital of Clontarf of which half was subjected to a 12-month
lock in requirement.

 

         As at 30 June 2025 no trading activity had commenced in the JV
and as such there are no results or expenses recorded.

 

 

6.    SHARE CAPITAL

 

 Deferred Shares - nominal value of 0.24p
                                       Number                 Share Capital  Share Premium

                                                              £'000          £'000
 At 1 January 2024                     2,370,826,117          5,690          -
 At 31 December 2024 and 30 June 2025  2,370,826,117          5,690          -

 

 

 

 

 

 Ordinary Shares - nominal value of 0.01p
 Allotted, called-up and fully paid:
                           Number                 Share Capital  Share Premium
                                                  £'000          £'000

 At 1 January 2024         5,193,326,117          519            12,737
 Issued during the period  2,000,000,000          200            500
 Share issue expenses                             -              (42)
 At 30 June 2024           7,193,326,117          719            13,195

 Issued during the period  1,000,000,000          100            350
 Share issue expenses      -                      -              (28)
 At 31 December 2024       8,193,326,117          819            13,517

 Issued during the period  -                      -              -
 Share issue expenses      -                      -              -
 At 30 June 2025           8,193,326,117          819            13,517

 

       Movements in issued share capital

 

There was no movement in the issued share capital in the six months to 30 June
2025.

 

 

7.    SHARE BASED PAYMENTS

 

SHARE OPTIONS

 

The Group issues equity-settled share-based payments to certain Directors and
individuals who have performed services for the Group. Equity-settled
share-based payments are measured at fair value at the date of grant.

 

Fair value is measured by the use of a Black-Scholes model.

 

The Group plan provides for a grant price equal to the average quoted market
price of the ordinary shares on the date of grant.

 

                               30 Jun 25                                                 30 Jun 24                                                 31 Dec 24
                               Options Number  Weighted average exercise price in pence  Options Number  Weighted average exercise price in pence  Options Number  Weighted average exercise price in pence

                               '000                                                      '000                                                      '000
 At 1 January                  980,500         0.09                                      500,500         0.03                                      500,000         0.035
 Issued                        -               -                                         320,000         0.0365                                    480,000         0.045
 Outstanding at end of period  980,500         0.09                                      820,500         0.1                                       980,500         0.09
 Exercisable at end of period  980,500         0.09                                      820,500         0.1                                       980,500         0.09

 

 

The Group capitalised expenses of £Nil (2024: £Nil) and expensed costs of
£Nil (2024: £209,835) relating to equity-settled share-based payment
transactions during the year.

 

 

 

 

 

 

Warrants

 

                               30 Jun 25                                            30 Jun 24                                                  31 Dec 24
                               Warrants   Weighted average exercise price in pence  Warrants Number  Weighted average exercise price in pence  Warrants  Weighted average exercise price in pence

                               Number                                               '000                                                       Number

                               '000                                                                                                            '000
 At 1 January                  435,683    0.25                                      533,183          0.22                                      533,183   0.22
 Issued                        -          -                                         -                -                                         -         -
 Expired                       (435,683)  0.25                                      -                -                                         (97,500)  0.065
 Exercisable at end of period  -          -                                         533,183          0.22                                      435,683   0.25

 

On 12 January 2022 the directors were granted a total of 435,683,300
warrants.  These warrants had a term of three years and an exercise price of
0.25p.  These warrants expired on 11 January 2025.

 

 

8.    POST BALANCE SHEET EVENTS

 

There are no significant post balance sheet events affecting the Company.

 

 

9.   The Interim Report for the six months to 30 June 2025 was approved by
the Directors on 9(th) September 2025.

 

 

10. The Interim Report will be available on the Company's website at
www.clontarfenergy.com (http://www.clontarfenergy.com) .

 

 

This announcement contains inside information for the purposes of Article 7 of
Regulation (EU) 596/2014.

 

ENDS

 

 

For further information please visit http://clontarfenergy.com
(http://clontarfenergy.com) or contact:

 

 

 Clontarf Energy                    +353 (0) 1 833 2833

 David Horgan, Chairman

 Jim Finn, Director

 Nominated & Financial Adviser      +44 (0) 20 7409 3494

 Strand Hanson Limited

 Rory Murphy

 Ritchie Balmer
 Broker                             +44 (0) 207 399 9400

 Novum Securities Limited

 Colin Rowbury

 Public Relations                   +44 (0) 207 138 3206

 BlytheRay

 Megan Ray
 Teneo                              +353 (0) 1 661 4055

 Luke Hogg

 Molly Mooney

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  IR EAKNNEDNSEFA

Recent news on Clontarf Energy

See all news